[Pharmacometabolic capacity of the liver and the effect of pancreozymin in chronic hepatitis, chronic pancreatitis and diabetes mellitus].
D000328:Adult; D000983:Antipyrine / Q000378:metabolism*; D001711:Biotransformation / Q000187:drug effects*; D002766:Cholecystokinin / Q000627:therapeutic use; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism*; D006505:Hepatitis / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D010195:Pancreatitis / Q000188:drug therapy / Q000378:metabolism*
D002766:Cholecystokinin; D000983:Antipyrine
Farmakometabolicheskaia sposobnost' pecheni i vliianie na nee pankreozimina u bol'nykh khronicheskim gepatitom, khronicheskim pankreatitom i sakharnym diabetom.